These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31398868)

  • 41. Procalcitonin and Other Biomarkers of Sepsis in Newborns in the Intensive Care Unit.
    Bartolovic D; Ignjatovic S; Stankovic S; Nada Majkić S
    EJIFCC; 2011 Mar; 22(1):24-30. PubMed ID: 27683386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analytical performances of a novel point-of-care procalcitonin assay.
    Dupuy AM; Bargnoux AS; Andreeva A; Zins C; Kuster N; Badiou S; Cristol JP
    Pract Lab Med; 2020 Jan; 18():e00145. PubMed ID: 31720356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the clinical performance of an automated procalcitonin assay for the quantitative detection of bloodstream infection.
    Kim KE; Han JY
    Korean J Lab Med; 2010 Apr; 30(2):153-9. PubMed ID: 20445333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of a new procalcitonin assay for the Siemens ADVIA Centaur with the established method on the B.R.A.H.M.S Kryptor.
    Sanders RJ; Schoorl M; Dekker E; Snijders D; Boersma WG; Ten Boekel E
    Clin Lab; 2011; 57(5-6):415-20. PubMed ID: 21755834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the BRAHMS KRYPTOR thyroglobulin "mini-recovery" test in thyroid healthy subjects.
    Verburg FA; Grelle I; Giovanella L; Reiners C
    Horm Metab Res; 2012 Jun; 44(7):555-7. PubMed ID: 22689210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Thyroglobulin Measurements Using Three Different Immunoassay Kits: A BRAMHS Tg-Plus RIA Kit, a BRAMHS hTg Sensitive Kryptor Kit, and a Beckman Coulter ACCESS Immunoassay Kit.
    Kim M; Jeon MJ; Kim WG; Lee JJ; Ryu JS; Cho EJ; Ko DH; Lee W; Chun S; Min WK; Kim TY; Shong YK; Kim WB
    Endocrinol Metab (Seoul); 2016 Sep; 31(3):462-468. PubMed ID: 27491718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical performance of the novel DiaSorin LIAISON(®) XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays.
    Krawczyk A; Hintze C; Ackermann J; Goitowski B; Trippler M; Grüner N; Neumann-Fraune M; Verheyen J; Fiedler M
    J Clin Virol; 2014 Jan; 59(1):44-9. PubMed ID: 24268764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker.
    Fernández Lopez A; Luaces Cubells C; García García JJ; Fernández Pou J;
    Pediatr Infect Dis J; 2003 Oct; 22(10):895-903. PubMed ID: 14551491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic relevance of procalcitonin, IL-6, and sICAM-1 in the prediction of infected necrosis in acute pancreatitis.
    Mándi Y; Farkas G; Takács T; Boda K; Lonovics J
    Int J Pancreatol; 2000 Aug; 28(1):41-9. PubMed ID: 11185709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors influencing antibiotic treatment cost and outcome in critically ill patients: a "real-life" study.
    Perić A; Šurbatović M; Kovačević SV; Antunović M; Veljović M; Djordjević D; Andjelić T; Zeba S; Dobrić S
    Vojnosanit Pregl; 2014 Dec; 71(12):1102-8. PubMed ID: 25638997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis.
    Georgopoulou AP; Savva A; Giamarellos-Bourboulis EJ; Georgitsi M; Raftogiannis M; Antonakos N; Apostolidou E; Carrer DP; Dimopoulos G; Economou A; Efthymiou G; Galanakis N; Galani L; Gargalianos P; Karaiskos I; Katsenos C; Kavatha D; Koratzanis E; Labropoulos P; Lada M; Nakos G; Paggalou E; Panoutsopoulos G; Paraschos M; Pavleas I; Pontikis K; Poulakou G; Prekates A; Sybardi S; Theodorakopoulou M; Trakatelli C; Tsiaoussis P; Gogos C; Giamarellou H; Armaganidis A; Meisner M;
    J Crit Care; 2011 Jun; 26(3):331.e1-7. PubMed ID: 20869839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in procalcitonin measurements between three BRAHMS-partnered immunoassays (Liaison, Elecsys and Architect).
    Eidizadeh A; Asif AR; von Ahsen N; Binder L; Schnelle M
    Clin Chem Lab Med; 2019 Aug; 57(9):e207-e210. PubMed ID: 30325730
    [No Abstract]   [Full Text] [Related]  

  • 53. Procalcitonin kinetics as a prognostic marker in severe sepsis/septic shock.
    Poddar B; Gurjar M; Singh S; Aggarwal A; Singh R; Azim A; Baronia A
    Indian J Crit Care Med; 2015 Mar; 19(3):140-6. PubMed ID: 25810608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extensive analytical evaluation of the performances of the new DiaSys PCT assay and comparison with Elecsys B·R·A·H·M·S PCT test on Roche Cobas and B·R·A·H·M·S PCT-sensitive Kryptor.
    Di Deo P; Vantaggiato C; Di Modugno A; Licari D; Savina PF; Zagliani A; Viganò C; Grimaldi G; Frassanito A; Lettera T; De Corato P; Ammirabile M; Ferraris Fusarini C; De Liso F; Maregnani A; Silvani I; Taverriti TPS; Ceriotti F; Vidali M
    Clin Chem Lab Med; 2024 Jan; 62(2):e44-e47. PubMed ID: 37531078
    [No Abstract]   [Full Text] [Related]  

  • 55. Procalcitonin as an early indicator of outcome in sepsis: a prospective observational study.
    Giamarellos-Bourboulis EJ; Tsangaris I; Kanni T; Mouktaroudi M; Pantelidou I; Adamis G; Atmatzidis S; Chrisofos M; Evangelopoulou V; Frantzeskaki F; Giannopoulos P; Giannikopoulos G; Gialvalis D; Gourgoulis GM; Kotzampassi K; Katsifa K; Kofinas G; Kontopidou F; Koratzanis G; Koulouras V; Koutsikou A; Koupetori M; Kritselis I; Leonidou L; Mega A; Mylona V; Nikolaou H; Orfanos S; Panagopoulos P; Paramythiotou E; Papadopoulos A; Papanikolaou X; Pavlaki M; Polychronopoulos V; Skoutelis A; Theodotou A; Vassiliaghou M; Douzinas EE; Gogos C; Armaganidis A;
    J Hosp Infect; 2011 Jan; 77(1):58-63. PubMed ID: 21131099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the LIAISON®XL and ARCHITECT IgG, IgM, and IgG avidity assays for the diagnosis of Toxoplasma, cytomegalovirus, and rubella virus infections.
    Genco F; Sarasini A; Parea M; Prestia M; Scudeller L; Meroni V
    New Microbiol; 2019 Apr; 42(2):88-93. PubMed ID: 30994178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comment to: Extensive analytical evaluation of the performances of the new DiaSys PCT assay and comparison with Elecsys B·R·A·H·M·S PCT test on Roche Cobas and B·R·A·H·M·S PCT-sensitive Kryptor.
    Masetto T; Grimmler M
    Clin Chem Lab Med; 2024 Jan; 62(2):e48-e50. PubMed ID: 37746855
    [No Abstract]   [Full Text] [Related]  

  • 58. A new strategy for the development of monoclonal antibodies for the determination of human procalcitonin in serum samples.
    Kremmer E; Meyer K; Grässer FA; Flatley A; Kösters M; Luppa PB; Krämer PM
    Anal Bioanal Chem; 2012 Jan; 402(2):989-95. PubMed ID: 22006244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus.
    Quintana G; Medina YF; Rojas C; Fernandez A; Restrepo JF; Rondon F; Iglesias A
    J Clin Rheumatol; 2008 Jun; 14(3):138-42. PubMed ID: 18525431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of procalcitonin concentration using the SphereLight 180 clinical auto-analyzer.
    Yamada H; Matsuda S; Ushio Y; Nakamura K; Kobatake S; Satomura S; Matsuura S
    Clin Chim Acta; 2008 Feb; 388(1-2):38-40. PubMed ID: 18021760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.